What policies does the UK government need to implement to support a sustainable life sciences industry? How would a future government partner with the healthcare and pharmaceutical sectors to achieve sustainability goals?

The pharmaceutical industry has a larger global carbon footprint than the automotive industry. Can innovative manufacturing technologies allow us to make our medicines in a more sustainable way?

The recent COP28 conference highlighted the urgency and pace needed to reach Net Zero goals. How can the healthcare, pharma, and wider life sciences sectors build on the outcomes of COP28?

Our own physical and mental health is intrinsically linked with the health of our environment. Can novel technologies allow us to reach a healthcare model that supports the health of both people and the planet?

Pharmaceutical innovation requires investment to bring novel therapies to the market. With ever-increasing pressures to achieve a greener industry, what are the sustainability expectations of future private and public sector investors?

Collaboration between pharma development, manufacturing and supply is essential for a more efficient and more sustainable pharma supply chain. How can technological advances facilitate a more connected and less wasteful supply chain?

There is an increasing desire for greener products amongst the public as a whole. How can the pharmaceutical and healthcare sectors adapt their products and processes to respond to the demands of future pharma customers?

Industries across the board are implementing new green technologies to achieve sustainability goals. What can the pharmaceutical and healthcare sectors learn from the industries at the forefront of the green revolution?

Focus: on medicines as a product including aspects of distribution and packaging and that you would also cover off governance piece – full descriptor to follow.